Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL

Fig. 2

Lipid status at baseline and Week 24 ±CVD or lipid-lowering therapy: LDL-C (a), Non-HDL-C (b), HDL-C (c), and triglycerides (d). Data presented represent mean (standard deviation). P < 0.05 between patients treated with lipid-lowering therapy versus not treated for all lipid parameters at baseline and change to Week 24, except for triglycerides which were significant (P < 0.05) at baseline only

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840